Global and United States Diabetic Lancing Device Market Report & Forecast 2022-2028

Diabetes is a global epidemic affecting an estimated 382 million people worldwide. The WHO projects that diabetes will be the 7th leading cause of death by 2030. An estimated 4 million people die annually from the complications associated with diabetes. Therefore, if the current trend associated with the prevalence of diabetes continues over the coming years, the number of diabetic patients across the globe would be tremendous after a decade.
Market Analysis and Insights: Global and United States Diabetic Lancing Device Market
This report focuses on global and United States Diabetic Lancing Device market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Diabetic Lancing Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Push Button Safety Lancets accounting for % of the Diabetic Lancing Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Increasing prevalence of diabetes will result in the rising demand for devices and products to monitor and control diabetes, eventually leading to increased consumption of lancets. Thus, the demand for lancets is expected to be enormous in the coming future.
Global Diabetic Lancing Device Scope and Market Size
Diabetic Lancing Device market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Diabetic Lancing Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Diabetic Lancing Device market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Push Button Safety Lancets
Pressure Activated Safety Lancets
Side Button Safety Lancets
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
B. Braun
Terumo Corporation
Becton Dickinson
Sanofi
Roche
Bayer
Novo Nordisk
Eli Lilly
Medtronic
Ypsomed Holding
Sarstedt
Abbott Laboratories
HTL-STREFA
Improve Medical
UltiMed
Allison Medical
Artsana